article thumbnail

Coherus sets steep discount for Humira copycat, plans direct sales

Bio Pharma Dive

The biotech will price its biosimilar Yusimry at 85% below Humira’s list price when it launches next month, and charge even less if bought through Mark Cuban’s pharmacy.

Sales 295
article thumbnail

Court rules for drugmakers in 340B fight over contract pharmacies

Bio Pharma Dive

The drugmakers sued HHS after regulators ordered them to stop restricting sales of 340B drugs to contract pharmacies. The decision is a win for Sanofi, Novo Nordisk and AstraZeneca.

Pharmacy 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers.

article thumbnail

FDA clears way for retail pharmacy sale of abortion pills

pharmaphorum

Retail pharmacies in the US will be able to dispense mifepristone-based therapies to end pregnancies after the FDA introduced changes to its regulatory framework for the products. Pharmacies will have to apply for certification to dispense mifepristone under the REMS.

article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.

Pharmacy 147
article thumbnail

MHRA bans OTC sale of codeine after recreational abuse reports

Pharmaceutical Technology

Codeine linctus has been reclassified from a pharmacy-only medicine to a prescription-only medicine in the UK.

Sales 130
article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

pharmaphorum

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. Detection of fraudulent activity. “The [implications of these stolen accounts] are twofold.

Pharmacy 138